Custom printed slabs

The Food and Drug Administration is forecasting a requirement for ten custom printed slabs designed for integration into a physical anthropomorphic breast CT phantom. Each of these slabs must be engineered to contain 20 synthetic lesions featuring various concentrations of iodine uptake. This procurement is managed by the Food and Drug Administration, with the Cdrh Acquisition Liaison serving as the primary program point of contact. While a specific contracting officer has not yet been named, the project is currently listed as a forecast opportunity.